Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18601247 | 0.91 | CYP1A2 (0.57) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL2770164 | 0.89 | HRH1 (0.54) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL4389586 | 0.84 | HRH1 (0.53) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL2780427 | 0.82 | SMN1; SMN2 (0.48) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL11354776 | 0.81 | HRH1 (0.50) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL27477298 | 0.78 | SMN1; SMN2 (0.56) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL11195301 | 0.78 | HRH3 (0.51) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL29485678 | 0.78 | HRH1 (0.73) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL230753 | 0.78 | HRH1 (0.73) | HRH1CA12CA1CA2CA9 | |
| SCHEMBL5669245 | 0.77 | CYP1A2 (0.63) | HRH1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| EP-4684872-A1 | DEVICE AND METHOD FOR WATER-IN-AIR GENERATION OF DROPLETS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-01-28 | — | — | EP | claimed |
| US-20230181466-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-06-15 | — | — | US | claimed |
| EP-4164693-A1 | NANOLIPOPROTEIN-POLYPEPTIDE CONJUGATES AND COMPOSITIONS, SYSTEMS, AND METHODS USING SAME | Genentech, Inc. (US) | 2023-04-19 | — | — | EP | claimed |
| US-20230038598-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-02-09 | — | — | US | claimed |
| US-11446238-B2 | Injectable dendrimer hydrogel nanoparticles | WAYNE STATE UNIVERSITY (US) | 2022-09-20 | — | — | US | claimed |
| EP-4054532-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-09-14 | — | — | EP | claimed |
| EP-4054533-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-09-14 | — | — | EP | claimed |
| WO-2021252803-A1 | NANOLIPOPROTEIN-POLYPEPTIDE CONJUGATES AND COMPOSITIONS, SYSTEMS, AND METHODS USING SAME | GENENTECH, INC. (US) | 2021-12-16 | — | — | WO | claimed |
| WO-2021152115-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-08-05 | — | — | WO | claimed |
| EP-1813614-B1 | Cytotoxic agents comprising new tomaymycin derivatives | SANOFI SA (FR) | 2011-10-05 | — | — | EP | claimed |
| US-20100092567-A1 | IMMUNOSTIMULATORY NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2010-04-15 | — | — | US | claimed |
| US-20090311276-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2009-12-17 | — | — | US | claimed |
| WO-2009143280-A2 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2009-11-26 | — | — | WO | claimed |
| EP-0550663-B1 | MODIFIED ANTIBODIES WITH CONTROLLED CLEARANCE TIME | TECHNICLONE INC (US) | 1998-01-21 | — | — | EP | claimed |
| EP-0783894-A1 | Antibodies modified at two separate sites | TECHNICLONE, INC. (US) | 1997-07-16 | — | — | EP | claimed |
| EP-0339264-B1 | Compounds for the introduction of a mercapto group to tyrosin | BOEHRINGER MANNHEIM GMBH (DE) | 1994-08-03 | — | — | EP | claimed |
| EP-0252951-A4 | TECHNETIUM-ANTIBODY CONJUGATE. | UNIV MELBOURNE (AU) | 1988-09-07 | — | — | EP | claimed |
| EP-0252951-A1 | TECHNETIUM-ANTIBODY CONJUGATE | THE UNIVERSITY OF MELBOURNE (AU) | 1988-01-20 | — | — | EP | claimed |
| WO-1987004164-A1 | TECHNETIUM-ANTIBODY CONJUGATE | THE UNIVERSITY OF MELBOURNE (AU) | 1987-07-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230038598-A1 | MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY | PCNA, BOD1L1, SARS1 | HRH1 4155/4885CA12 4005/4885CA1 4232/4885 |
| US-11446238-B2 | Injectable dendrimer hydrogel nanoparticles | PAM, UACA, FLT1 | HRH1 3255/4885CA12 3814/4885CA1 4603/4885 |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | HRH1 4356/4885CA12 2449/4885CA1 4488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.